Search results
HCL Tech Q1 Preview: Weak deals, client spending to dent profits by 5-7%
Business Standard India· 12 hours agoAccording to analysts, HCL Tech is likely to report a revenue increase of 6-7 per cent year-on-year...
Meet Vijay Upadhyaya, India's 'Proud' Cultural Envoy Who Gave PM Modi A Musical Welcome In Vienna -...
News18· 12 hours agoPrime Minister Narendra arrived in Vienna on Wednesday to a musical welcome in the famous Austrian...
Bansal Wire shares up 33% after a strong listing; Should investors buy, sell or hold? | Stock Market...
Livemint· 12 hours agoBansal Wire share price was listed with a 37.52 per cent premium at ₹352.05 per share on the BSE,...
Google Pixel Watch 3 leak highlights upgrades in display, smaller bezels
91 Mobiles· 12 hours agoTech giant Google is anticipated to unveil the Pixel Watch 3 at this year’s Made by Google event, which will take place on August 13th. Notably, several details about the upcoming smartwatch ...
Jon Bon Jovi's Mother Carol Bonjovi Passes Away At 83; Singer Says She Will Be Missed in Sombre...
Pinkvilla· 13 hours agoAs per the publication, Carol is survived by her husband, three children Jon, Anthony, and Matthew,...
Emcure Pharma IPO Lists On Stock Market With 31.45% Gains, In Line With Expectations; Hold, Buy or...
News18· 13 hours ago“The listing aligns with pre-listing expectations, fuelled by the robust investor response,” said...
ATEEZ rebounds on 'Billboard 200', celebrating 5 consecutive weeks on the chart | K-pop Movie News -...
The Times of India· 13 hours agoATEEZ continues to make headlines with their impressive performance on the 'Billboard 200' chart....
Bansal Wire Lists At 39% Premium, Emcure Pharma Gains 31% At Debut
Latest India News· 13 hours agoBoth Bansal Wire and Emcure Pharmaceuticals IPO closed for public subscription on July 5.
Who Is Landon Barker? Know All About Travis Barker’s Son As The Drummer Is ‘Proud’ To Have Him On...
Koimoi· 13 hours agoBlink-182 drummer Travis Barker shares son Landon Barker with ex-wife Shanna Moakler and is “so...
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Business Standard India· 13 hours agoEmcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a...